Patent Assignment
Reel/Frame 040662/0916
Dissolution of Celltech R&D, Inc. and Subsequent Distribution of Assets into Darwin Molecular Corporation
Recorded: 2016-11-22
Pages: 8
Assignor
CELLTECH R&D, INC.
Executed: 2004-12-28
Assignee
DARWIN MOLECULAR CORPORATION
1631 220TH STREET S.E., BOTHELL, WASHINGTON, 98201
Covered Properties
(6)
Polynucleotides Encoding Antibodies Specific for Sclerostin
Application:
12/958,195 →
Publication:
US 2011/0195453
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Application:
13/101,434 →
Publication:
US 2011/0206677
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Application:
13/101,455 →
Publication:
US 2011/0206678
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 12, 2014
From: UCB MANUFACTURING, INC.
To: UCB PHARMA S.A.
Reel/Frame 033516/0493 →
Assignment of Assignor's Interest
Nov 22, 2016
From: WINKLER, DAVID G.; SHI, JIYE; LATHAM, JOHN
To: CELLTECH R&D, INC.
Reel/Frame 040398/0431 →
Merger
Nov 22, 2016
From: DARWIN MOLECULAR CORPORATION
To: UCB MANUFACTURING, INC.
Reel/Frame 040398/0489 →